Concord Biotech

quarterly
yearly
ParticularsMar '25Jun '25Sep '25Dec '25Mar '26
Revenue439.26217.67260.41287.75341.43
Expenses254.18160.43177.02197.61227.17
EBITDA199.8175.08101.84108.96133.88
Operating Profit183.6458.7985.7486.24114.16
Profit Before Tax183.5558.7385.6886.15114.08
Net Profit140.3944.0663.0663.6488.47
Financial Ratios
Operating Profit Margin46.12%37.54%42.15%37.79%41.00%
Net Profit Margin32.66%21.60%25.73%24.08%27.23%
Earning Per Share (Diluted)13.424.216.036.088.46
Dividends Per Share0.000.000.000.000.00